News From Multiple Perspectives

Johnson & Johnson Agrees to US$5.5 Billion Settlement in Talc Lawsuits

Published July 28, 2026 at 8:32 AM UTC

Authored by
Every article published on DirectionFreeNews undergoes editorial review by our editorial team. Our editors research publicly available information from multiple trusted news organizations, compare differing perspectives, verify key facts, and publish balanced summaries intended to help readers better understand important events. Our editorial process is designed to reduce editorial bias by considering multiple reputable sources rather than relying on a single viewpoint

Johnson & Johnson has reached a US$5.5 billion settlement to resolve the majority of lawsuits claiming its talc-based baby powder caused cancer. The deal, announced through a subsidiary's bankruptcy filing, aims to compensate tens of thousands of plaintiffs while allowing the company to avoid prolonged litigation. For years, J&J has faced allegations that its talc products contained asbestos and led to ovarian cancer and mesothelioma. The company has consistently denied wrongdoing, citing scientific studies it says show the products are safe. The settlement, one of the largest product liability agreements in history, will be funded through a trust established under the subsidiary's Chapter 11 reorganization. Affected claimants will have the opportunity to vote on the plan, and if approved, they will receive payments in exchange for dropping their lawsuits. However, a small number of cases are not included, and some plaintiffs have chosen to opt out. J&J's move is part of a broader strategy to contain legal exposure, but the company still faces other talc-related litigation and regulatory scrutiny. For consumers, the settlement does not change the fact that J&J stopped selling talc-based baby powder in North America in 2020, switching to cornstarch-based alternatives. The outcome will be closely watched as a precedent for how large corporations manage mass tort liabilities.